Structural characterization of two copper(II) complexes with oxime-type ligands

Two new linear Cu^II complexes [Cu(L¹)₂] (I) (HL¹ = (E)-3,5-dichloro-2-hydroxy benzaldehyde O-methyl oxime) and [Cu(L²)₂] (II) (HL² = (E)-3,5-dichloro-2-hydroxy benzaldehyde O-ethyl oxime) are synthesized and characterized by elemental analysis, IR, UV-Vis, and X-ray diffraction methods. X-ray crystallographic analyses indicate that complexes I and II have a similar structure consisting of one Cu^II ion and two L⁻ units. In the complexes, the Cu^II ion lying on an inversion centre is four-coordinated in a trans-CuN₂O₂ square planar geometry by two phenolate O and two oxime N atoms from two symmetry-related N,O-bidentate oxime-type ligands. However, the crystal structure of the two complexes is different: complex I forms an infinite three-dimensional supramolecular network structure through intermolecular hydrogen bonding and π...π interaction, while complex II forms an infinite one-dimensional supramolecular structure through intermolecular hydrogen bonds.     

Synthesis,crystal structure,and properties of copper(II) and manganese(II) complexes with azide and 3,4-di(2′-pyridyl)-1,2,5-oxadiazole

Two transition metal complexes with azide and 3,4-di(2′-pyridyl)-1,2,5-oxadiazole (dpo), [Cu₂(dpo)₂(N₃)₄] (1), and [Mn(dpo)₂(N₃)₂] (2), have been synthesized and characterized by single-crystal X-ray diffraction. The Cu(II) complex is binuclear with double end-on (EO) azido bridges, in which each Cu(II) ion assumes a distorted square pyramidal geometry, and each EO azido bridge adopts a quasi-symmetric fashion. In contrast, the Mn(II) complex is mononuclear, in which the Mn(II) ion is ligated by two dpo ligands and two terminal azide ions, with a distorted octahedron geometry. Magnetic studies on the Cu(II) complex revealed that the double EO azido bridge mediates ferromagnetic coupling with J=12.8 cm⁻¹.     

A twofold interpenetrated 3-D Cu(II) coordination polymer based on 5-(pyridin-4-yl)isophthalic acid: synthesis,crystal structure,and magnetic properties

A new copper(II) coordination polymer, [Cu(PIA)·2H₂O]_n (1) [H₂PIA = 5-(pyridin-4-yl)isophthalic acid], has been synthesized and characterized by elemental analysis, IR spectroscopy, TGA, powder, and single-crystal X-ray diffraction. Structural analysis shows that each PIA^2? in 1 bridges three Cu(II) ions, and likewise each Cu(II) ion connects to three PIA^2? ligands, giving a 3-D framework with utp topology and left-/right-handed helical channels. Interestingly, two such identical frameworks interlock with each other to generate a twofold interpenetrated structure that is stabilized by hydrogen bonding and π–π interactions. In addition, the thermal stability and the magnetic properties of 1 have been investigated.     

COPPER(II) COMPLEXES OF 1-[O-ALLYLPHENOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL (ALPRENOLOL)

Abstract

Complexation of Cu(II) with the antihypertension drug Alprenolol (HAlp) under different conditions (metal/ligand ratios and solvents) results in the formation of two complexes - a binuclear green one, Cu₂Alp₂Cl₂ (1), and a mononuclear violet species CuAlp₂·2H₂O (2). Single crystals of (1) were isolated and its structure determined by X-ray diffraction. In the complex Alprenolol molecules are bidentately coordinated and each Cu atom is bound with NH, and bridged by the deprotonated OH group of the ligand to the second Cu centre. The chloride ions are coordinated to copper as terminal ligands. The mononuclear complex (2) was characterized using electronic and IR spectra, EPR, magnetochemical, calorimetric, thermogravimetric methods and elemental analysis. Copper is coordinated through O^? and N of OH and NH groups of the ligands in a distorted tetrahedral structure. The structure includes also two solvent molecules per CuAlp₂ unit.     

基于含有硫醚基团的吡啶烷基酰胺配体的铜配合物的合成和结构表征

合成和表征了含有硫醚基团的吡啶烷基酰胺配体2-(甲硫基)-N-[2-(2-吡啶)甲基]乙酰胺(HL1)和2-(甲硫基)-N-[2-(2-吡啶)乙基]乙酰胺(HL2)及其3个铜的配合物,{[Cu(L1)(CH₃OH)](OTf)}_n(1)(Otf=三氟甲磺酸根),{[Cu(L2)(OTf)]·CH₃OH}_n(2)和[Cu(HL2)(CH₃OH)Cl](3),并通过X-射线单晶衍射分析确定了其晶体结构。配合物1和2均为含有铜的一维配位聚合物,而配合物3为单核铜配合物。分析了配合物中铜离子的配位特点及可能的形成原因。     

混价四核铜(I/II)配合物[Cu_2L_2][Cu(pht)_2]_2的合成、晶体结构及性质研究

报道四核铜配合物[Cu2L2][Cu(pht)2]2[Hpht:苯妥英,即5,5-二苯基-2,2咪唑烷酮;L:N-(3-氨基丙基)二乙醇胺]的溶剂热合成、晶体结构及其性质研究.该晶体属单斜晶系,P21/n空间群,晶胞参数:a=0.9240(1)nm,b=2.4559(2)nm,c=1.5572(2)nm,β=97.489(2)o,V=3.5035(7)nm3,Dc=1.499Mg/m3(g/cm3),Z=2,F(000)=1636,μ=1.270mm-1,R1=0.0503,wR2=0.1135[I2σ(I)],GOF=1.014.XPS结合X射线单晶结构分析,表明该配合物分子有混价铜组成,包括两个Cu(I)和两个Cu(II),其中每个Cu(I)分别与两个苯妥英配体提供的氮原子配位,N—Cu(I)—N的夹角为177.1°,每个Cu(II)与L配体的五个配位原子配位(N2O3),形成一个稍变形四方锥结构,两个Cu(II)通过N-(3-氨基丙基)二乙醇胺中的一个羟基氧桥连接形成双核阳离子,琼脂扩散法测试结果表明配合物、配体和铜盐对3种受试细菌均有一定的活性.配合物与DNA的相互作用测定研究表明,该配合物是以插入方式与小牛胸腺DNA结合.     

基于含有硫醚基团的吡啶烷基酰胺配体的铜配合物的合成和结构表征

合成和表征了含有硫醚基团的吡啶烷基酰胺配体2-(甲硫基)-N-[2-(2-吡啶)甲基]乙酰胺(HL1)和2-(甲硫基)-N-[2-(2-吡啶)乙基]乙酰胺(HL2)及其3个铜的配合物,{[Cu(L1)(CH₃OH)](OTf)}_n(1)(Otf=三氟甲磺酸根),{[Cu(L2)(OTf)]·CH₃OH}_n(2)和[Cu(HL2)(CH₃OH)Cl](3),并通过X-射线单晶衍射分析确定了其晶体结构。配合物1和2均为含有铜的一维配位聚合物,而配合物3为单核铜配合物。分析了配合物中铜离子的配位特点及可能的形成原因。     

Studies on the manganese and copper complexes derived from chiral Schiff base: synthesis,structure, cytotoxicity and DNA/BSA interaction

Abstract

Three new manganese and copper complexes, [Mn(ONO-(S)L¹)₂] (1), [Cu(ONO-(R)L²)]₄·2CH₃OH (2), and [Mn₃(ONO-(S)L³)₄(OAc)₄(H₂O)₂] (3), {[H₂L¹ = (S)-2-phenyl-2-(2-hydroxy-5-chlorobenzylideneamino)ethane-1-ol], H₂L² = (R)-2-(2-hydroxy-5-chlorobenzylideneamino)butane-1-ol] and H₂L³ = (S)-2-phenyl-2-(2-hydroxy-3-methoxybenzylideneamino)ethane-1-ol]}, have been synthesized. The crystal structures of 1–3 were determined through single-crystal X-ray diffraction. The structure of mononuclear 1 shows a six-coordinate octahedral geometry around the manganese ion. Complex 2 is a five-coordinate tetranuclear copper complex with the central Cu atoms adopting distorted square pyramidal geometry. Complex 3 shows a trinuclear structure with the six-coordinate Mn ions surrounded by four L³ ligands and acetate ions. The in vitro cytotoxicity screening revealed that the 1–3 had substantial cytotoxicity against three cancer cell lines (HepG2, MDA-MB-231, and A549), even higher than that of cisplatin. Inspiringly, 2 derived from (R)-Schiff base ligand H₂L² was more potent against MDA-MB-231 cells. Interaction of 1–3 with calf-thymus DNA (CT-DNA) has been investigated using UV-vis, viscosity and thermal denaturation experiments. It was found that 1 binds with DNA through intercalation while 2 and 3 interact with DNA probably through groove-binding and electrostatic mode. In addition, the capability of the complexes to bind with bovine serum albumin was monitored using some spectral techniques. The metal ions, chiral and nuclearity have significant influences on the properties of the title compounds.     

Synthesis,characterization, and biological evaluation of new copper complexes of naphthyl pyrazole ligands

Two naphthalene pyrazole ligands were synthesized using KOH/DMSO and Cu catalyst and characterized with FT-IR, ESI-MS, ¹H, and ¹³C NMR spectroscopies. The crystal structures of 1-(2-methylnaphthalen-1-yl)-1H-pyrazole (MeNap-Pz) ligand have been determined with X-ray crystal structure analysis. Reaction of the ligands with Cu(NO₃)₂x3.5H₂O gave two new complexes and characterized with magnetic susceptibility, molar conductance, FT-IR, LCMS-MS, ICP-OES, NMR, thermogravimetric analysis, and ESR spectra. The spectral data of the ligands are coordinated to the metal ion through the nitrogen atoms of the pyrazole ring. Consequently, it has been determined that [Cu(MeNap-Pz)₂(NO₃)]NO₃.2H₂O complex showed square planar geometry and [Cu(NapMe-Pz)₂(NO₃)₂].H₂O complex showed octahedral geometry. All compounds were screened for in vitro antibacterial activity and copper complexes have been shown to be effective on bacteria.     

Cu(II) complexes with 4-amino-3,5-dimethyl isoxazole and substituted aromatic aldehyde Schiff bases: synthesis,crystal structure,antimicrobial activity,DNA binding and cleavage studies

Three isoxazole Schiff bases 2-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)-6-methoxyphenol (L¹), 2-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)-4,6-diiodophenol (L²), 2-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)-6-bromo-4-chlorophenol (L³), and their Cu(II) complexes [Cu(L¹)₂] (1), [Cu(L²)₂] (2) and [Cu(L³)₂] (3) were synthesized. All the complexes have been characterized by elemental analysis, FT-IR, ESI mass, UV-Visible, ESR, TGA, magnetic moments, and single-crystal X-ray diffraction analysis. Based on analytical data, a square planar geometry is assigned to the Cu(II) complexes with N₂O₂ donors from the Schiff base ligands. The single-crystal X-ray diffraction measurements of 1 and 2 confirmed the square planar geometry. DNA binding studies from electronic absorption titrations, viscosity measurements, and fluorescence quenching studies indicated an intercalation mode of binding of Cu(II) complexes with CT-DNA. DNA cleavage experiments of Cu(II) complexes with supercoiled plasmid pBR322 DNA have also been investigated by agarose gel electrophoresis in the presence of H₂O₂ (oxidative cleavage) and UV light (photolytic cleavage). The synthesized compounds were screened for antibacterial (Escherichia coli, Pseudomonas putida, Klebsiella pneumoniae, Bacillus subtillis and Staphylococcus aureus) and antifungal (Candida albicans and Aspergillus niger) activities by the paper disk method. The Cu(II) complexes showed better activity than corresponding Schiff bases.     

Synthesis, properties, and molecular and crystal structure of hexaaquacopper(IV) bis(diaquacuprato-μ3-trihydroxyglutarato)germanate(IV) dihydrate [Cu(H2O)6][Ge(μ3-Thgl)2{Cu(H2O)2}2] · 2H2O

A procedure for the synthesis of the heteropolymetallic germanium(IV) and copper(II) complex with trihydroxyglutaric acid (H₅Thgl) [Cu(H₂O)₆][Ge(μ₃-Thgl)₂{Cu(H₂O)₂}₂] · 2H₂O (I) was developed and the complex was isolated for the first time in the solid state. The product was characterized by elemental analysis, powder X-ray diffraction, thermogravimetry, and IR spectroscopy. Compound I was studied by X-ray crystallography. The crystals are monoclinic, a = 10.216(2)?, b = 12.272(3)?, c = 10.679(2)?, β = 93.13(3)°, V = 1336.9(5)?³, Z = 2, space group P2₁/n, R1 = 0.0261 for 3616 reflections with I > 2σ(I). Compound I is composed of bimetallic [Ge(μ₃-Thgl)₂{Cu(H₂O)₂}₂]²⁻ anions, [Cu(H₂O)₆]²⁺ cations, and water molecules of crystallization. In the centrosymmetric trinuclear complex anion, the Ge(1) atom is bound by two fully deprotonated bridging ligands to two Cu atoms. The Ge(1) atom is coordinated at distorted octahedron vertices by six hydroxyl oxygen atoms of two Thgl⁵⁻ ligands (average Ge(1)-O distance is 1.8874(13)?). The Cu coordination polyhedron in the anion is an extended square pyramid (4 + 1) formed by the bridging hydroxyl oxygen atom (Cu(1)-O(3), 2.0039(12) ?), two carboxyl oxygen atoms (average CU(1)-O distance is 1.9674(14)?) of two Thgl⁵⁻ ligands, and two water oxygen atoms in equatorial and axial positions (Cu(1)-O, 1.9761(13) and 2.3643(14)?, respectively). In the centrosymmetric cation, the Cu coordination polyhedron is an extended square bipyramid (4 + 2). The equatorial Cu-O bond length is 1.9428(14) ? (average), the axial Cu-O bond is elongated to 2.5151(14)?. The cations and anions are combined by H-bonds.     

Synthesis and Structural Characterization of the Co(III) Complex with 2'-[1-(2-Pyridinyl)-Ethylidene]-Oxamohydrazide (Hapsox): The Crystal Structure of Bis-{2'-[1-(2-Pyridinyl)-Ethylidene]-Oxamohydrazido} Cobalt(III) Perchlorate, [Co(apsox)2]ClO4

The synthesis of a novel ligand 2′-[1-(2-pyridinyl)-ethylidene]-oxamohydrazide (Hapsox), from a series of 2-acetylpyridine acylhydrazones, and its complex with Co(III), which is the first in this series of complexes are described. Both the ligand and the complex were characterized by elemental analysis, IR, ¹H-NMR, and ¹³C-NMR spectra, and the structure of the complex [Co(apsox)₂]ClO₄ was determined by X-ray structural analysis. It was established that [Co(apsox)₂]ClO₄ has an octahedral geometry with two tridentate apsox ligands in monoanionic form. Structural characteristics, lengths of the bonds, and angles between the bonds were typical for Co(III) complexes of distorted octahedral geometry. Both direct and template synthesis afforded the same geometrical isomer of the complex with two apsox ligands meridionally bound to the central metal ion, even in the case when equimolar quantities of Co(ClO₄)₂ and Hapsox were applied.     

Mononuclear Cu(II) complexes of novel salicylidene Schiff bases: synthesis and mesogenic properties

Two new Schiff base ligands 1 and 2 (where 1 = 4-(2-hydroxybenzilidenamino)-phenyl-4-(decyloxy)-2-(pent-4-enyloxy)benzoate, 2 = 4-(4-(decyloxy)-2-hydroxybenziliden amino)-phenyl-4-(decyloxy)-2-(pent-4-enyloxy)benzoate) and their copper (Cu)(II) complexes have been synthesised and characterised. The derivatives were fully characterised structurally, and their mesomorphic behaviour was investigated by polarised optical microscopyand differential scanning calorimetry. The structure of Cu(II) complex having 1 as ligand (3) was determined by X-ray diffraction. The Schiff base ligands exhibit enantiotropic nematic phases, the Cu(II) complex 4 shows monotropic nematic phase behaviour, while compound 3 does not show mesomorphism.     

STRUCTURES AND PROPERTIES OF COPPER(II) COMPLEXES WITH IMINODIACETATO AND IMIDAZOLE OR RELATED LIGANDS. I. CRYSTAL STRUCTURE OF AQUA(IMIDAZOLE) (IMINODIACETATO)COPPER(II) MONOHYDRATE AND (IMIDAZOLE)(N-CARBOXYMETHYL-D,L-THREONINATO)COPPER(II)

Abstract

The crystal structures of two mixed-ligand copper(II) complexes having iminodiacetate(2-) (IDA) or N-carboxymethyl-D,L-threoninato(2-) ion (CMT) as terdentate ligands and imidazole (ImH) as an N-heterocyclic ligand are reported. Both compounds crystallize in the orthorhombic system, space group Pbca with Z = 8. Aqua(imidazole)(iminodiacetato)copper(II) monohydrate (I,R = 0.065, R _w = 0.075) consists of H₂O molecules and [Cu(IDA)(ImH)(H₂O)] complex units in a hydrogen bonding network. The structure of imidazole(N-carboxymethyl)-D,L-threoninatocopper(II) (IV, R = 0.066, Rω 0.078) is built up of hydrogen bonded polynuclear chains. In both compounds the Cu(II) ion exhibits a flattened and distorted square-based pyramidal coordination, with a terdentate aminoacidate ion, IDA or CMT, and one ImH ligand at the base and H₂O (in I) or the oxygen atom of the OH side chain from one adjacent CMT ion (in IV) as the fifth apical ligand. The nearly coplanar conformation of the two five-membered chelate rings in I and IV is discussed in connection with the known structure of corresponding aquacomplexes (with H₂O instead of ImH) and the ability of terdentate aminoacids to give ternary Cu(II) complexes having two N-heterocyclic donors (2 ImH or one 2,2′-bipy) per Cu(II) atom.     

Crystal structures of some lanthanide(III) complexes with acylhydrazone and their coordination chemistry

Three new lanthanide(III) complexes with N-(2-propionic acid)-salicyloylhydrazone (H₂L, C₁₀H₁₀N₂O₄) ligand [La(HL)₂(NO₃)(H₂O)₂]₃ ·4H₂O(I), [Gd(HL)₃] · 2(C₂H₅)₃ N(II) and [Er(L)(HL)(H₂O)₂] · 2H₂O(III) has been synthesized and characterized by elemental analyses, IR, UV, and molar conductivity. The crystal structures of three complexes have been determined by X-ray single-crystal diffractometer. In complex I, the La³⁺ ion is ten-coordinated by two tridentate ligands, one bidentate nitrate, and two water molecules. In complex II, the Gd³⁺ ion has a coordination number of nine by three tridentate ligands. In complex III, the Er³⁺ ion is eight-coordinated by two tridentate ligands and two water molecules. In all structures, tridentate ligands are coordinated by carboxyl O and acyl O atoms and azomethine N atom to form two stable five-membered rings sharing one side in the keto mode as indicated by the results of crystal structures and infrared spectral analysis.     

A copper(II) complex with 2-(2′-pyridyl)benzimidazole and l-arginine: synthesis,structure, antibacterial activities,and DNA interaction

A Cu(II) complex with 2-(2′-pyridyl)benzimidazole and l-arginine has been synthesized and investigated by elemental analysis, molar conductivity, IR, UV/vis, and X-ray diffraction. The complex crystallizes in the triclinic space group P1 with six molecules in a unit cell of dimensions a?=?10.6397(5)?Å, b?=?19.2178(8)?Å, c?=?20.0387(9)?Å, α?=?75.3670(10)°, β?=?79.4670(10)°, γ?=?87.4470(10)°, V?=?3897.6(3)?ų, R ₁?=?0.0408, and wR ₂?=?0.0502. The complex contains six crystallographically independent complexes, Cu1, Cu2, Cu3, Cu4, Cu5, and Cu6, which have a distorted square-pyramidal geometry. The complex was screened for its in vitro antibacterial activities against two Gram-positive (Bacillus subtilis and Staphylococcus aureus) and two Gram-negative (Escherichia coli and Salmonella) micro-organisms. The complex exhibited good antibacterial activities against the micro-organisms compared with HPB and Cu(ClO₄)₂. Interaction of the complex with DNA was studied by electronic absorption spectroscopy, fluorescence spectroscopy, circular dichroic spectroscopy, viscosity measurements, and agarose gel electrophoresis. Results suggest that the complex could bind to CT-DNA via partial intercalation, and cleave the plasmid DNA with involvement of hydroxyl radicals, and probably singlet oxygen-like copper-oxo species in the presence of ascorbate.     

Synthesis,structure, and magnetic properties of two dimer paddle-wheel CuII toluate complexes with nitronyl nitroxide radicals

Two new paddle-wheel dimeric copper complexes, [Cu₂(4-MePhCOO)₄(NITmPy)₂] (1) and [Cu₂(3-MePhCOO)₄(NITmPy)₂] (2) (NITmPy?=?2-(3-pyridyl)-4,4,5,5-tetramethyl-4,5-dihydro1H-imidazolyl-1-oxyl-3-oxide), were synthesized by reaction of copper toluate and NITmPy. Single crystal X-ray analyses revealed that both complexes are symmetrical dimers. Cu with four deprotonated methyl-benzoate bridging ligands form a paddle-wheel core and pyridyl nitrogen of radical ligands at the apical position. Based on the Cu–Cu axis of 1 and 2, we exploited the steric constraints of the methyl groups and induced the paddle-wheel. Two magnetic exchange pathways with strong antiferromagnetic interaction between dimeric Cu^II ions and weak antiferromagnetic interaction between NITmPy ligands exist in the complexes. IR and powder X-ray diffraction of the complexes were also studied.     

Polymeric and monomeric dipicolinate complexes with 4-hydroxymethyl pyridine: spectral, structural, thermal and electrochemical characterization

Polymeric copper(II), [Cu(μ-dpc)(μ-4-hymp)] _n (1), and monomeric nickel(II), [Ni(dpc)(4-hymp)(H₂O)₂]·H₂O (2), (dpc: dipicolinate, 4-hymp: 4-hydroxymethyl pyridine), dipicolinate complexes have been prepared and characterized by spectroscopic (IR, UV–Vis, EPR), thermal (TG/DTA), X-ray diffraction technique and electrochemical methods. In both the dipicolinate complexes, the dpc dianion acts as a tridentate ligand. In polymeric copper(II) complex, the 4-hymp and dpc ligands adopt a bridging position between the Cu(II) centers, forming the elongated octahedral geometry. The polymeric chains are linked to one another via O–H···O hydrogen bond interactions, forming the 3-D polymeric structure. The Ni(II) ion is bonded to dpc ligand through pyridine N atom together with one O atom of each carboxylate group, two aqua ligands and N pyridine atom of 4-hymp, forming the distorted octahedral geometry. The Ni(II) complexes are connected to one another via O–H···O hydrogen bonds, forming R ₄²(18) motifs in 2-D pattern. The powder EPR spectra of copper(II) complex have indicated that the paramagnetic center is in rhombic symmetry with the Cu²⁺ ion having distorted octahedral geometry. IR and UV–Vis spectroscopes all agree with the observed crystal structure.     

Structural conversion of an oxazolidine ligand upon treatment with copper(I) and (II) halides; structural,spectral, theoretical and docking studies

Abstract

In this work, the 2-(2-(pyridin-2-yl)oxazolidin-3-yl)ethanol (AEPC) ligand was prepared under solvent free conditions using ultrasonic irradiation, before reaction with a Cu(NO₃)₂/KSCN mixture, CuCl₂ and CuI, the products of which were characterized by elemental analysis, UV-Vis, FT-IR spectroscopy and single-crystal X-ray diffraction. The X-ray analyses results revealed that AEPC, after reactions with the three copper(I/II) halides, gave structures ([Cu(DEA)Cl₂] (2), DEA?=?diethanolamine, [Cu(BHEG)₂] (3), BHEG?=?bis(2-hydroxyethyl)glycinato); however, it retains its structure on treatment with Cu(NO₃)₂/KSCN mixture ([Cu(AEPC)(NCS)₂] (1)). The geometrical parameters for the complexes were compared with the Cambridge Structural Database (CSD) and coordination modes for thiocyanate ion were extracted. In the crystal structure of 1, the copper ion has a distorted square-pyramidal geometry and a CuN^pyN₂^NCSN^tertO^alc environment in which the AEPC acts as NN'O-donor in a facial coordination mode. In the crystal structure of 2, the copper ion has a Cu(N^sec)(O^alc)₂Cl₂ environment and distorted square-pyramidal geometry in which the DEA ligand is coordinated as a mer-NO₂-donor. The copper ion in 3 has a CuN₂O₄ environment and distorted octahedral geometry. The ability of these compounds to interact with the nine biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) was investigated by Docking calculations and compared with that of doxorubicin. The thermodynamic stability of 1 and its isomer and also charge distribution patterns were studied by DFT and NBO analysis, respectively.     

Heteronuclear complexes of oxorhenium(V) with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO2(VI) and their biological activities

Heteronuclear complexes containing oxorhenium(V), with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO₂(VI) ions were prepared by the reaction of the complex ligands [ReO(HL¹)(PPh₃)(OH₂)Cl]Cl (a) and/or [ReO(H₂L²)(PPh₃)(OH₂)Cl]Cl (b), where H₂L¹?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(5,6-diphenyl-1,2,4-triazine-3-ylhydrazone) and H₃L²?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(1H-benzimidazol-2-ylhydrazone), with transition and actinide salts. Heterodinuclear complexes of ReO(V) with Fe(III), Co(II), Ni(II), Cu(II) and Cd(II) were obtained using a 1?:?1 mole ratio of the complex ligand and the metal salt. Heterotrinuclear complexes were obtained containing ReO(V) with UO₂(VI) and Cu(II) using 2?:?1 mole ratios of the complex ligand and the metal salts. The complex ligands a and b coordinate with the heterometal ion via a nitrogen of the heterocyclic ring and the nitrogen atom of the C=N⁷ group. All transition metal cations in the heteronuclear complexes have octahedral configurations, while UO₂(VI)?complexes have distorted dodecahedral geometry. The structures of the complexes were elucidated by IR, ESR, electronic and ¹H NMR spectra, magnetic moments, conductance and TG-DSC measurements. The antifungal activities of the complex ligands and their heteronuclear complexes towards Alternaria alternata and Aspergillus niger showed comparable behavior with some well-known antibiotics.